David C. Hastings, Chief Financial Officer at Arbutus Biopharma Corp (ABUS), sold 44,366 shares at $3.28 ($146K) on 2025-02-04, disclosed to the SEC on 2025-02-05.
Scheduled sale ($146k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.28 | 22,183 | $73K | 50.0% |
| 2 | $3.28 | 22,183 | $73K | 50.0% |
| Total | $3.28 avg | 44,366 | $146K | 100% |
| Filing → |
| SCYX | BUY | 2017-06-22 | $35K | — | Filing → |
| INCY | SELL | 2014-06-06 | $10.5M | — | Filing → |
| INCY | SELL | 2014-02-18 | $18.1M | — | Filing → |